Global Liquid Biopsy Market is Projected to Reach $12,933 Million by 2030

According to a new market intelligence report by BIS Research titled ‘Global Liquid Biopsy Market – Analysis and Forecast, 2020-2030’, The liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030

BIS Research Report: https://bisresearch.com/industry-report/global-liquid-biopsy-market.html

This growth has been primarily attributed to the rising number of cancer cases coupled up with the growing awareness pertaining to non-invasive detection approaches, the increasing adoption of inorganic growth strategies by key players in the market, and the increasing research funding from the leading organizations such as the U.S. National Institute of Health, globally.

The market is expected to grow at a significant growth rate due to opportunities such as the introduction of informatics and technological innovations for a large customer base and increasing adoption of cancer and other diseases testing services.

Request for Sample: https://bisresearch.com/requestsample?id=982&type=download

However, there are significant challenges that are restraining the market growth. These challenges include false negatives and positives, limited and ambiguous reimbursement scenario, expected implementation of Patient Protection and Affordable Care (PPACA) Act (for research used kits and consumables), and existing diagnostic confidence of medical community on liquid biopsy procedures. Despite the substantial investments made by the conglomerate companies of the healthcare industry, the clinical application of liquid biopsy is predominantly limited to treatment monitoring, however adoption is expected to increase owing to the recent approval of GUARDANT360. Several factors such as low confidence of the physicians, uncertainty pertaining to approval scenario, and a lack of favorable reimbursement policies are the leading factors hampering the growth of the global liquid biopsy market.

Key Questions Answered in the Report
What are the major market drivers, challenges, and opportunities in the global liquid biopsy market?

What are the key development strategies which are implemented by the major players to sustain in the competitive market?

Which is the dominant product type developed by the leading and emerging players for liquid biopsy?

What are the key technologies that have been used by leading players in the global liquid biopsy market for the development of diagnostic and research solutions for cancer?

How each segment of the market is expected to grow during the forecast period from 2020 to 2030?

Comments

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...

Market Research Reports

Search This Blog